延续性护理对慢性心力衰竭稳定期患者生活质量的影响

Effect of continuous nursing care on quality of life in patients with chronic heart failure at stable stage

目的探讨延续性护理对慢性心力衰竭稳定期患者生活质量、自护能力和再入院率的影响。方法选取2016年10月至2017年10月本院收治的慢性心力衰竭患者122例,随机分为延续性护理组和常规护理组,每组61例。出院后,常规护理组仅给予常规出院指导,延续性护理组在常规护理组的基础上给予延续性护理。观察记录两组患者护理前、护理后3个月和护理后6个月的自护能力和生活质量评分,比较护理6个月后再次入院率。结果护理前,两组MLHFQ和ESCA评分比较,差异均无统计学意义(均P>0.05)。护理后,两组社会限制、体力限制、症状和情绪4个维度的评分均显著降低(均P<0.05),自护责任感、自我概念、健康知识和自护技能4个维度的评分均显著提高(均P<0.01),且延续性护理组的各评分变化幅度均显著高于常规护理组(均P<0.05)。延续性护理组再次入院率为6.56%,显著低于常规护理组的19.67%(χ2=4.6038,P=0.0319)。结论延续性护理可以提高慢性心力衰竭稳定期患者的生活质量和自护能力,降低再入院率,值得临床广泛应用。

Objective To investigate the effect of continuous nursing care on quality of life, self-care ability, and readmission rate in patients with stable chronic heart failure. Methods A total of 122 patients with chronic heart failure admitted to our hospital were randomly divided into a continuous care group and a routine care group, 61 cases for each group. After discharge, the routine care group only gave regular discharge guidance;in addition, the continuous care group gave continuous care. The self-care ability and quality of life scores of the 2 groups before and 3 and 6 months after the treatment were observed and compared;and the re-admissionrates after 6 months’ nursing care were compared. Results There were no statistical differences in the scores ofMLHFQ and ESCAbetween the two groups before the treatment (P>0.05). After the nursing care,The scores of social restriction, physical limitation, symptoms, and emotions were significantly lower (all P<0.05), and the scores of self-care responsibility, self-concept, health knowledge, and self-care skills were higher after than before the nursing care in both groups, and were better in the continuous care group thanin the conventional care group (all P<0.05).The re-hospitalization rate was 6.56% in the continuous care group, and was 19.67% in the conventional care group (χ 2=4.603 8, P=0.031 9). Conclusion Continuing care can improve the quality of life and self-care ability of patients with stable chronic heart failure, and reduce the readmissionrate, so it is worth for clinical application.